Berry Genomics Overview
- Year Founded
-
2010

- Status
-
Public
- Employees
-
1,448

- Stock Symbol
-
000710

- Investments
-
2
- Share Price
-
$1.76
- (As of Monday Closing)
Berry Genomics General Information
Description
Berry Genomics Co Ltd is a biotechnology company. It providess gene sequencing detection equipment and services.
Contact Information
Website
www.berrygenomics.comCorporate Office
- Building 5, Yard 4, Shengshengyuan Road
- Science and Technology Park, Changping District
- Beijing
- China
Corporate Office
- Building 5, Yard 4, Shengshengyuan Road
- Science and Technology Park, Changping District
- Beijing
- China
Berry Genomics Stock Performance
As of 17-Feb-2025, Berry Genomics’s stock price is $1.76. Its current market cap is $624M with 354M shares.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.76 | $1.60 | $0.89 - $1.83 | $624M | 354M | 20.7M | -$0.11 |
Berry Genomics Financials Summary
As of 30-Sep-2024, Berry Genomics has a trailing 12-month revenue of $154M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 423,599 | 585,411 | 593,364 | 1,091,755 |
Revenue | 154,425 | 162,747 | 203,133 | 220,251 |
EBITDA | (42,479) | (46,046) | (23,517) | (871) |
Net Income | (39,266) | (60,382) | (36,963) | (18,068) |
Total Assets | 362,132 | 386,700 | 464,322 | 551,273 |
Total Debt | 16,324 | 42,826 | 50,465 | 62,644 |
Berry Genomics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Berry Genomics Patents
Berry Genomics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4400637-A1 | Method for constructing capture library having high test performance, and kit | Pending | 09-Sep-2021 | ||
US-20220348911-A1 | Method to construct whole-genome high-throughput sequencing library and test kit thereof | Pending | 29-Dec-2020 | ||
US-20220348996-A1 | Method and kit for non-specific amplification of natural short-fragment nucleic acid | Pending | 02-Aug-2019 | ||
US-20220251549-A1 | Method for constructing capture library and kit | Pending | 25-Jul-2019 | ||
US-20220298505-A1 | Method for constructing pacbio sequencing library | Pending | 26-Jun-2019 | C12N15/1093 |
Berry Genomics Signals
Berry Genomics Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Berry Genomics Investments (2)
Berry Genomics’s most recent deal was a Early Stage VC with Belief BioMed for . The deal was made on 19-Jun-2018.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Belief BioMed | 19-Jun-2018 | Early Stage VC | Drug Discovery | ||
Sanomics | Later Stage VC | Biotechnology |
Berry Genomics ESG
Risk Overview
Risk Rating
Updated January, 20, 2021
31.54 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,042
Rank
Percentile

Pharmaceuticals
Industry
of 193
Rank
Percentile

Biotechnology
Subindustry
of 165
Rank
Percentile

Berry Genomics Exits (1)
Berry Genomics’s most recent exit was on 19-Jun-2018 from Belief BioMed. The exit was categorized as with 3 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Belief BioMed | 19-Jun-2018 | Completed |
|
Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Berry Oncology | Fuzhou, China | 2017 |
Berry Genomics FAQs
-
When was Berry Genomics founded?
Berry Genomics was founded in 2010.
-
Where is Berry Genomics headquartered?
Berry Genomics is headquartered in Beijing, China.
-
What is the size of Berry Genomics?
Berry Genomics has 1,448 total employees.
-
What industry is Berry Genomics in?
Berry Genomics’s primary industry is Biotechnology.
-
Is Berry Genomics a private or public company?
Berry Genomics is a Public company.
-
What is Berry Genomics’s stock symbol?
The ticker symbol for Berry Genomics is 000710.
-
What is the current stock price of Berry Genomics?
As of 17-Feb-2025 the stock price of Berry Genomics is $1.76.
-
What is the current market cap of Berry Genomics?
The current market capitalization of Berry Genomics is $624M.
-
What is Berry Genomics’s current revenue?
The trailing twelve month revenue for Berry Genomics is $154M.
-
What is Berry Genomics’s annual earnings per share (EPS)?
Berry Genomics’s EPS for 12 months was -$0.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »